Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Robot-assisted radical cystectomy and intracorporeal orthotopic neobladder: 1-year functional outcomes.

Obrecht F, Youssef NA, Burkhardt O, Schregel C, Randazzo M, Padevit C, Wiklund P, John H.

Asian J Androl. 2020 Jan 7. doi: 10.4103/aja.aja_125_19. [Epub ahead of print] No abstract available.

PMID:
31929193
2.

Does seminal vesicle-sparing robotic radical prostatectomy influence postoperative prostate-specific antigen measured with an ultrasensitive immunoassay?

Burkhardt O, Neuenschwander JE, John H, Randazzo M.

Swiss Med Wkly. 2018 Nov 26;148:w14685. doi: 10.4414/smw.2018.14685. eCollection 2018 Nov 19.

3.

Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B.

Lancet Infect Dis. 2018 Jan;18(1):95-107. doi: 10.1016/S1473-3099(17)30592-3. Epub 2017 Oct 13.

PMID:
29037960
4.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B.

Cochrane Database Syst Rev. 2017 Oct 12;10:CD007498. doi: 10.1002/14651858.CD007498.pub3. Review.

5.

Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis.

Odermatt J, Friedli N, Kutz A, Briel M, Bucher HC, Christ-Crain M, Burkhardt O, Welte T, Mueller B, Schuetz P.

Clin Chem Lab Med. 2017 Nov 27;56(1):170-177. doi: 10.1515/cclm-2017-0252.

6.

Prognostic value of procalcitonin in respiratory tract infections across clinical settings.

Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P.

Crit Care. 2015 Mar 6;19:74. doi: 10.1186/s13054-015-0792-1.

7.

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.

Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE.

Clin Chem Lab Med. 2015 Mar;53(4):583-92. doi: 10.1515/cclm-2014-1015.

8.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Review.

PMID:
23877944
9.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007498. doi: 10.1002/14651858.CD007498.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Oct 12;10 :CD007498.

10.

Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient.

Eden G, Burkhardt O, Clajus C, Kielstein JT.

Clin Kidney J. 2012 Aug;5(4):350-1. doi: 10.1093/ckj/sfs076.

11.

Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.

Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B.

Clin Infect Dis. 2012 Sep;55(5):651-62. doi: 10.1093/cid/cis464. Epub 2012 May 9.

12.

Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.

Lorenzen JM, Broll M, Kaever V, Burhenne H, Hafer C, Clajus C, Knitsch W, Burkhardt O, Kielstein JT.

Clin J Am Soc Nephrol. 2012 Mar;7(3):385-90. doi: 10.2215/CJN.05690611. Epub 2012 Jan 5.

13.

Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma.

Burhenne H, Kielstein JT, Burkhardt O, Kaever V.

Biomed Chromatogr. 2012 Jun;26(6):681-3. doi: 10.1002/bmc.1732. Epub 2011 Oct 24.

PMID:
22020627
14.

Rapid HPLC-MS/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma.

Beste KY, Burkhardt O, Kaever V.

Clin Chim Acta. 2012 Jan 18;413(1-2):240-5. doi: 10.1016/j.cca.2011.09.042. Epub 2011 Oct 6.

PMID:
21996080
15.

Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.

Lode H, Schmoele-Thoma B, Gruber W, Ahlers N, Fernsten P, Baker S, Razmpour A, Siber G, Hackell J, Lockhart S, Burkhardt O, Welte T, de Roux A.

Vaccine. 2011 Jul 12;29(31):4940-6. doi: 10.1016/j.vaccine.2011.04.132. Epub 2011 May 17.

PMID:
21596077
16.

Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.

Kielstein JT, Burkhardt O.

Curr Pharm Biotechnol. 2011 Dec;12(12):2015-9. Review.

PMID:
21554216
18.

Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis.

Bahte SK, Bertram A, Burkhardt O, Martens-Lobenhoffer J, Goedecke V, Bode-Böger SM, Hiss M, Kielstein JT.

J Antimicrob Chemother. 2010 Jun;65(6):1312-4. doi: 10.1093/jac/dkq118. Epub 2010 Apr 9. No abstract available.

PMID:
20382726
19.

Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.

Burkhardt O, Thon S, Burhenne J, Welte T, Kielstein JT.

Int J Antimicrob Agents. 2010 Jul;36(1):93-4. doi: 10.1016/j.ijantimicag.2010.02.017. Epub 2010 Apr 8. No abstract available.

PMID:
20381320
20.

Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock.

Pletz MW, Bloos F, Burkhardt O, Brunkhorst FM, Bode-Böger SM, Martens-Lobenhoffer J, Greer MW, Stass H, Welte T.

Intensive Care Med. 2010 Jun;36(6):979-83. doi: 10.1007/s00134-010-1864-y. Epub 2010 Mar 25.

PMID:
20336279
21.

Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.

Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, Hummers-Pradier E, Welte T.

Eur Respir J. 2010 Sep;36(3):601-7. doi: 10.1183/09031936.00163309. Epub 2010 Feb 25.

22.

Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.

Kielstein JT, Eugbers C, Bode-Boeger SM, Martens-Lobenhoffer J, Haller H, Joukhadar C, Traunmüller F, Knitsch W, Hafer C, Burkhardt O.

Nephrol Dial Transplant. 2010 May;25(5):1537-41. doi: 10.1093/ndt/gfp704. Epub 2009 Dec 22.

PMID:
20031929
23.

A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients.

Burkhardt O, Kielstein JT.

Expert Rev Anti Infect Ther. 2010 Jan;8(1):11-4. doi: 10.1586/eri.09.121.

PMID:
20014897
24.

Antibiotic dosing in extended dialysis.

Kielstein JT, Burkhardt O.

Clin Infect Dis. 2009 Dec 15;49(12):1963; author reply 1964. doi: 10.1086/648504. No abstract available.

PMID:
19929396
25.

Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.

Burkhardt O, Kumar V, Schmidt S, Kielstein JT, Welte T, Derendorf H.

Int J Antimicrob Agents. 2010 Jan;35(1):96-7. doi: 10.1016/j.ijantimicag.2009.09.007. Epub 2009 Nov 6. No abstract available.

PMID:
19896806
26.

Clinical pharmacokinetics and pharmacodynamics of tigecycline.

Barbour A, Schmidt S, Ma B, Schiefelbein L, Rand KH, Burkhardt O, Derendorf H.

Clin Pharmacokinet. 2009;48(9):575-84. doi: 10.2165/11317100-000000000-00000. Review.

PMID:
19725592
27.

10 years' experience with the pneumococcal quinolone moxifloxacin.

Burkhardt O, Welte T.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):645-68. doi: 10.1586/eri.09.46. Review.

PMID:
19681692
28.

Dose matters: dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy.

Kielstein JT, Burkhardt O, Bode-Boeger SM.

Crit Care Med. 2009 Aug;37(8):2491; author reply 2491-2. doi: 10.1097/CCM.0b013e3181aee6af. No abstract available.

PMID:
19609131
29.

High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis.

Burkhardt O, Ellis S, Burhenne H, Kaever V, Hadem J, Kielstein JT, Welte T.

Int J Antimicrob Agents. 2009 Nov;34(5):491-2. doi: 10.1016/j.ijantimicag.2009.04.002. Epub 2009 May 14. No abstract available.

PMID:
19446441
30.

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection.

Herpers BL, Vlaminckx B, Burkhardt O, Blom H, Biemond-Moeniralam HS, Hornef M, Welte T, Kuijper EJ.

Clin Infect Dis. 2009 Jun 15;48(12):1732-5. doi: 10.1086/599224.

PMID:
19435431
31.

Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.

Barbour A, Schmidt S, Rout WR, Ben-David K, Burkhardt O, Derendorf H.

Int J Antimicrob Agents. 2009 Sep;34(3):231-5. doi: 10.1016/j.ijantimicag.2009.03.019. Epub 2009 May 2.

PMID:
19411164
32.

Extended daily dialysis does not affect the pharmacokinetics of anidulafungin.

Burkhardt O, Kaever V, Burhenne H, Kielstein JT.

Int J Antimicrob Agents. 2009 Sep;34(3):282-3. doi: 10.1016/j.ijantimicag.2009.03.003. Epub 2009 Apr 14. No abstract available.

PMID:
19369040
33.

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.

Burkhardt O, Rauch K, Kaever V, Hadem J, Kielstein JT, Welte T.

Int J Antimicrob Agents. 2009 Jul;34(1):101-2. doi: 10.1016/j.ijantimicag.2009.01.015. Epub 2009 Mar 10. No abstract available.

PMID:
19278835
34.

Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis--a single case.

Kielstein JT, Lorenzen J, Kaever V, Burhenne H, Broll M, Hafer C, Burkhardt O.

Nephrol Dial Transplant. 2009 Jul;24(7):2283-5. doi: 10.1093/ndt/gfp060. Epub 2009 Feb 18.

PMID:
19225017
35.

Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient.

Goedecke VA, Clajus C, Burkhardt O, Martens-Lobenhoffer J, Bode-Boger SM, Kielstein JT, Hiss M.

Scand J Infect Dis. 2009;41(2):155-7. doi: 10.1080/00365540802613095.

PMID:
19085620
36.

[Modern artificial respiration concepts in the treatment of acute respiratory distress syndrome].

Ellis S, Burkhardt O, Welte T.

Dtsch Med Wochenschr. 2008 Nov;133(48):2522-6. doi: 10.1055/s-0028-1100951. Epub 2008 Nov 19. Review. German.

PMID:
19021086
37.

Effect of protein binding on the pharmacological activity of highly bound antibiotics.

Schmidt S, Röck K, Sahre M, Burkhardt O, Brunner M, Lobmeyer MT, Derendorf H.

Antimicrob Agents Chemother. 2008 Nov;52(11):3994-4000. doi: 10.1128/AAC.00427-08. Epub 2008 Sep 8.

38.

Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.

Burkhardt O, Hafer C, Langhoff A, Kaever V, Kumar V, Welte T, Haller H, Fliser D, Kielstein JT.

Nephrol Dial Transplant. 2009 Jan;24(1):267-71. doi: 10.1093/ndt/gfn472. Epub 2008 Aug 23.

PMID:
18723863
39.

Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.

Barth J, Jäger D, Mundkowski R, Drewelow B, Welte T, Burkhardt O.

J Antimicrob Chemother. 2008 Sep;62(3):575-8. doi: 10.1093/jac/dkn212. Epub 2008 May 30.

PMID:
18515790
40.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
41.

[Chikungunya: fever and joint pains after vacation in a tropical area].

Ahrenstorf G, Burkhardt O, Witte T, Stoll M, Schmidt RE.

Dtsch Med Wochenschr. 2008 Feb;133(9):406-8. doi: 10.1055/s-2008-1046727. German.

PMID:
18288627
42.

Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.

Burkhardt O, Pletz MW, Mertgen CP, Welte T.

Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):123-30. Review.

PMID:
18221168
43.

Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis.

Burkhardt O, Joukhadar C, Traunmüller F, Hadem J, Welte T, Kielstein JT.

J Antimicrob Chemother. 2008 Jan;61(1):224-5. Epub 2007 Oct 26. No abstract available.

PMID:
17965030
44.

Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves.

Schmidt S, Schuck E, Kumar V, Burkhardt O, Derendorf H.

Expert Opin Drug Discov. 2007 Jun;2(6):849-60. doi: 10.1517/17460441.2.6.849.

PMID:
23489002
45.

Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit.

Burkhardt O, Köhnlein T, Wrenger E, Lux A, Neumann KH, Welte T.

Scand J Rheumatol. 2007 Mar-Apr;36(2):119-24.

PMID:
17476618
46.

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.

Burkhardt O, Derendorf H, Welte T.

Expert Opin Pharmacother. 2007 Feb;8(2):237-56. Review.

PMID:
17257093
47.

Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.

Burkhardt O, Kumar V, Katterwe D, Majcher-Peszynska J, Drewelow B, Derendorf H, Welte T.

J Antimicrob Chemother. 2007 Feb;59(2):277-84. Epub 2006 Dec 21.

PMID:
17185298
48.

Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosis.

Burkhardt O, Lode H, Welte T, Merker HJ.

Micron. 2007;38(6):572-9. Epub 2006 Nov 16.

PMID:
17127071
49.

Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.

Burkhardt O, Derendorf H, Jäger D, Kumar V, Madabushi R, Röhl K, Barth J.

Scand J Infect Dis. 2006;38(10):904-8.

PMID:
17008236
50.

Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?

Burkhardt O, Lehmann C, Madabushi R, Kumar V, Derendorf H, Welte T.

J Antimicrob Chemother. 2006 Oct;58(4):822-9. Epub 2006 Aug 2.

PMID:
16885180

Supplemental Content

Loading ...
Support Center